Influence of Body Mass Index on Survival and Prognosis in Squamous Cell Carcinoma of Head and Neck
Authors Li P, Sun L, Sun L
Received 14 February 2020
Accepted for publication 22 April 2020
Published 7 May 2020 Volume 2020:12 Pages 3203—3210
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Eileen O'Reilly
Peng Li,1 Liyan Sun,2 Luyan Sun3
1Department of Head Neck and Thyroid Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China; 2Department of Orthodontics, SATH Hospital of Stomatology, Henan University , Zhengzhou, People’s Republic of China; 3Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China
Correspondence: Peng Li
Department of Head Neck and Thyroid Surgery, Affiliated Cancer Hospital of Zhengzhou University, Jinshui District, Zhengzhou, Henan 450008, People’s Republic of China
Objective: Differences in body mass index (BMI) were used to analyze the survival and prognosis of SCCHN patients.
Patients and Methods: A retrospective cohort study was conducted to select 323 patients who underwent surgical treatment for SCCHN from June 2013 to June 2016. The patients were divided into a healthy BMI group (BMI< 24kg/m2), an overweight group (24kg/m2≤BMI< 28kg/m2) and an obese group (BMI≥ 28 kg/m2). Various statistical methods were used to summarize and analyze clinical data, complications, disease specific survival (DSS), the overall survival (OS), and recurrence-free survival (RFS) within the last 3 y.
Results: At 3 y, OS (54.40%) and DSS (51.94%) were slightly lower in the obese group compared with the overweight (64.62%, 61.92%) and healthy BMI groups (64.66%, 65.02%), but no statistical significance was found in DSS (P=0.178), OS (P=0.123) and RFS (P=0.362). The difference in operation duration (P=0.008) and bleeding volume (P=0.001) in obese patients was consistent with those in diabetes mellitus (P=0.002) and coronary heart disease (P=0.000). A high incidence of pharyngeal fistula was observed in obese (P=0.014) and overweight patients (P=0.025), but mouth floor fistula (P=0.038), lung infection (P=0.047), fat liquefaction (P=0.003) and lower extremities deep venous thrombosis (P=0.020) were only found in the obese group. Cox univariatable and multivariatable analysis showed that clinical stage, T stage, and N stage were independent prognostic factors for patients with SCCHN, which was not related to BMI.
Conclusion: BMI was associated with a higher probability of complications. However, BMI had no significant correlation with 3-year OS, RFS and DSS, and was not a prognostic indicator for patients with SCCHN.
Keywords: body mass index, SCCHN, DSS, OS, RFS, prognosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]